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Introduction: Ultrasound measurements of rectus
femoris cross-sectional area (RFCSA) are clinically
useful measurements in chronic obstructive pulmonary
disease (COPD) and critically ill patients. Technical
considerations as to the type of probe used, which
affects image resolution, have limited widespread
clinical application. We hypothesised that measurement
of RFCSA would be similar with linear and curvilinear
probes.
Methods: Four studies were performed to compare the
use of the curvilinear probe in measuring RFCSA. Study 1
investigated agreement of RFCSA measurements using
linear and curvilinear probes in healthy subjects, and in
patients with chronic respiratory disease. Study 2
investigated the intra-rater and inter-rater agreement
using the curvilinear probe. Study 3 investigated the
agreement of RFCSA measured from whole and spliced
images using the linear probe. Study 4 investigated the
applicability of ultrasound in measuring RFCSA during the
acute and recovery phases of an exacerbation of COPD.
Results: Study 1 showed demonstrated no difference in
the measurement of RFCSA using the curvilinear and
linear probes (308±104 mm2 vs 320±117 mm2, p=0.80;
intraclass correlation coefficient (ICC)>0.97). Study 2
demonstrated high intra-rater and inter-rater reliability of
RFCSA measurement with ICC>0.95 for both. Study 3
showed that the spliced image from the linear probe
was similar to the whole image RFCSA (308±103.5 vs
263±147 mm2, p=0.34; ICC>0.98). Study 4 confirmed
the clinical acceptability of using the curvilinear probe
during an exacerbation of COPD. There were
relationships observed between admission RFCSA and
body mass index (r=+0.65, p=0.018), and between
RFCSA at admission and physical activity levels at 4
weeks post-hospital discharge (r=+0.75, p=0.006).
Conclusions: These studies have demonstrated that
clinicians can employ whole and spliced images from
the linear probe or use images from the curvilinear
probe, to measure RFCSA. This will extend the clinical
applicability of ultrasound in the measurement of muscle
mass in all patient groups.
INTRODUCTION
B-mode ultrasound imaging is a widely used
technique. More recently, its clinical use has
been extended to the assessment of periph-
eral skeletal muscle wasting, with single and
sequential measurement of the quadriceps
rectus femoris (RF) muscle cross-sectional
area (RFCSA).
1–5 RFCSA has been shown to
correlate with volitional measures of quadri-
ceps strength1 2 and this approach has char-
acterised peripheral muscle wasting in
patients with chronic obstructive pulmonary
disease (COPD).1 2 This non-volitional tech-
nique, with high levels of intra-rater and
interoccasion reliability,1 3 4 6–8 has been
employed by us and by others, as a tool to
assess skeletal muscle wasting in critically ill
patients.3 9 Despite these supportive data,
there are limitations to the use of this ultra-
sound method.
KEY MESSAGES
▸ These studies have shown that a curvilinear
ultrasound probe is as effective as a linear ultra-
sound probe in measuring the rectus femoris
cross-sectional area.
▸ Additionally, splicing images using a linear ultra-
sound probe can also be used to measure the
rectus femoris cross-sectional area if an
adequately sized linear probe or a curvilinear
probe is not available.
▸ Furthermore, using a curvilinear ultrasound
probe to the measure rectus femoris cross-
sectional area in a cohort of patients with an
exacerbation of chronic obstructive pulmonary
disease has demonstrated a correlation between
the rectus femoris cross-sectional area, and
activity.
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Conventionally, a higher frequency (6–10 MHz) linear
ultrasound probe has been used to measure RFCSA, as
the high resolution permits clear definition of the
border of the quadriceps rectus femoris muscle.10
However, the linear ultrasound probe has limited depth
penetration and imaging window width,1 10 which can
adversely affects the reliability and reproducibility of the
measurement. For example, in young critically ill trauma
patients with substantial peripheral muscle bulk on
admission,3 in those morbidly obese patients with
increased subcutaneous fat and in fluid overloaded crit-
ical care patients, the image window width and depth
limits acquisition of the whole RFCSA image. In contrast,
the lower frequency (2–5 MHz) curvilinear ultrasound
probe has greater depth penetration10 and window
width but lower resolution,10 which has raised concerns
about its usefulness when measuring RFCSA.
Recent systematic reviews evaluating the use of muscle
ultrasound for measurement of peripheral skeletal
muscle reported a paucity of studies investigating the
effect of frequency and resolution on muscle area mea-
surements.11 12 Indeed, previous studies comparing the
use of linear and curvilinear ultrasound probes have
been inconclusive, with one study suggesting that there
may be a bias towards larger measurements with a linear
probe,13 and another demonstrating similarity between
the probes.14 One previous study has directly compared
the linear and curvilinear probes to measure cross-
sectional area, albeit this was a non-clinical study using
vessels filled with different density media as the simula-
tion model.15
In the current study, we hypothesised that there would
be no difference in RFCSA measurements using a linear
and curvilinear ultrasound probe between healthy sub-
jects and patients with chronic respiratory disease,
including interoperator and interoccasion measure-
ments using the lower frequency probe. Additionally we
hypothesised that spliced images using the linear probe
would provide similar RFCSA whole image measurement.
Finally, we assessed the clinical feasibility of using the
lower frequency curvilinear probe in patients with




Ethical approval for the study was obtained from the
local ethical review board (Westminster National
Research Ethics Committee). All healthy subjects and
patients provided written and informed consent.
Healthy volunteer subjects were recruited from labora-
tory and clinical staff. Patients with stable chronic
respiratory disease undergoing assessment for initiation
of home mechanical ventilation were recruited from the
Lane Fox Respiratory Unit, St Thomas’ Hospital,
London, UK, and patients with COPD were recruited
during hospital admission for an acute exacerbation.
Validation studies
Four separate validation studies were performed.
▸ Study 1 investigated the agreement of RFCSA mea-
sured using linear and curvilinear probes at two-third
and three-fifth of the distance between the anterior
superior iliac spine (ASIS) and the superior border
of the patella, in healthy subjects and in patients with
stable chronic respiratory disease (n=32).
▸ Study 2 investigated the intra-rater and inter-rater
agreement using the lower frequency curvilinear
probe. Intra-rater reliability measurements were made
in 10 healthy subjects who had RFCSA measurements
taken at two-third and three-fifth the distance
between ASIS and the superior border of the patella
on two separate occasions using the curvilinear ultra-
sound probe, within 10 days of each other, by one
operator (SM). Inter-rater reliability measurements
were made in 10 participants with chronic respiratory
failure (7 with COPD and 3 with obesity hypoventila-
tion syndrome), who had RFCSA measurements per-
formed on the same day by two independent
operators (SM and AT), using the curvilinear ultra-
sound probe. For each patient, each operator took
three measurements at two-third and at three-fifth
distance from ASIS to superior boder of the patella.
▸ Study 3 investigated the agreement of RFCSA measured
from whole and ‘spliced’ images using the higher fre-
quency linear probe in healthy subjects and in those
with stable chronic respiratory failure (n=32).
▸ Study 4 investigated the clinical applicability of ultra-
sound measurements using the lower frequency curvi-
linear probe to track the change in RFCSA and, in
particular, to investigate the relationship between
changes in RFCSA and physical activity, during the
acute and the recovery phases of an exacerbation of
COPD (n=18).
RFCSA measurement protocol
Whole image aquistion—RFCSA was measured at two-third
and three-fifth distance from ASIS to the superior
border of the patella. The patient was placed in a semi-
recumbent position with a pillow under the knee. The
probe was placed perpendicularly to the long axis of the
femur, as previously reported, with minimal change in
the angle of the probe.1 16 17 The operator positioned
the probe on the surface of the thigh to avoid distorting
the underlying tissue. Measurements were taken in a
standardised manner—RFCSA measurements were taken
by the liner probe first and then by the curvilinear
probe. Real-time, B-mode ultrasound images were
acquired using a 6 MHz linear probe with a 38 mm array
(Sonosite S-ICU, SonoSite Inc, Japan) and 2–5 MHz
curvilinear probe with a 60 mm array (Sonosite S-ICU,
SonoSite Inc). The mean value of three consecutive
measurements of RFCSA using each ultrasound probe
was recorded.
Spliced image aquistion—Whole and matched ‘spliced’
RFCSA images were acquired using the linear ultrasound
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probe at both two-third and three-fifth distance. RFCSA
measurements were calculated off-line using the Image J
program (National Institutes of Health, Maryland, USA).
Both operators took images sequentially and then ana-
lysed results off-line at a later date so as to be blinded to
the results. Spliced measurements involved taking two
images, one of each half of the RF muscle, at the same
point, for example, at three-fifth distance, one image of
the lateral half of the RF muscle and at the same point
an image of the medial half of the RF muscle. A land-
mark within the muscle was used as the point at which
each half of the muscle would be measured so as to
avoid overlapping of the images (figure 1). The two
measurements of each half of the muscle (lateral and
medial) were summated to provide the overall ‘spliced
image’ cross-sectional area.
Physical activity measurement
A subset of patients admitted with an acute exacerbation
of COPD (AECOPD) also wore a uniaxial accelerometer
activity monitor (Actiwatch Spectrum, Phillips
Respironics, Murraysville, Pensylvania, USA) during their
hospital admission, to assess the relationship between
changes in RFCSA and physical activity.
18–21 Patients were
requested to wear the accelerometer for the duration of
hospital stay as well as for 28 days following hospital dis-
charge. Participants were asked to wear the accelerom-
eter for 24 h/day. Data for inpatient admission were
included if the accelerometer was worn for a minimum
of 3 days and at least for 10 h during the daytime to
allow assessment of physical activity. For follow-up data,
an average of 7 days of data was used to assess physical
activity.
Statistical analysis
Results are presented as mean±SD, unless otherwise
stated. Statistical analysis was performed using Prism V.6
(Graphpad, California, USA). Independent t tests and
Bland-Altman analysis were used to compare the two
modes of scanning, and intraclass correlation coeffi-
cients (ICC) were calculated to determine agreement
between the two methods.
RESULTS
Study 1: RFCSA agreement between the linear and
curvilinear probe
Participants
Fifty consecutive participants were enrolled (37 healthy
subjects and 13 patients with chronic respiratory
failure). Participants were not excluded on the basis of
body mass index (BMI). Of those with chronic respira-
tory failure, 12 had COPD and 1 had restrictive lung
disease. The ages of the healthy cohort and chronic
respiratory failure cohort were 36±9 and 72±10 years,
respectively.
Whole RFCSA image acquisition using the linear and
curvilinear probes
Thirty-two participants had whole RFCSA image aquisi-
tion using the linear probe visualised at the two-third
and 14 at three-fifth distance from the ASIS and patella
(figure 2A, B), the remaining 18 and 36 participants,
respectively, could not have their RFCSA wholly visualised
with the linear probe. The main reason the muscle
could not wholly be visualised at three-fifth distance was
due to the muscle being too large to fit the width of the
probe. However, all participants had whole RFCSA image
aquisition using the curvilinear probe. The age of these
32 participants was 49±21 years (patient cohort (n=13)
72±10 years; healthy cohort 32±4 years).
RFCSA agreement measured at two-third distance from ASIS
and superior border of the patella
There was no difference between RFCSA measurements
using the linear and curvilinear probes at two-third dis-
tance from ASIS and superior border of the patella (308
±104 mm2 vs RFCSA 320±117 mm
2, 3.8% difference;
p=0.80). The ICC was 0.97 (table 1). Bland-Altman ana-
lysis of linear and curvilinear RFCSA measurements
demonstrated the majority of values within the 95% con-
fidence limits of −62.4 to 39.4 with a bias of −11.6
±26.0 mm2 (figure 3A). The mean coefficient of vari-
ation (CV) was 2.6% for linear images and 2.6% for
images taken with the curvilinear probe.
RFCSA agreement measured at three-fifth distance from the
ASIS and superior border of the patella
There was no difference between RFCSA measurements
taken using the linear and curvilinear probes (327±103
vs 334±117 mm2, 2.1% difference p=0.93) at three-fifth
distance from the ASIS and superior border of the
patella with an ICC of 0.98 (table 1). CV for whole
linear images was 2.3% and 2.2% for images taken with
the curvilinear probe. Bland-Altman analysis demon-
strated a bias of −7.0±22.2 mm2 (figure 3B) with allFigure 1 A representative example of imaging splicing.
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values lying within the 95% confidence limits (−50.5 to
36.5).
Comparison of healthy subjects and patient cohort at
two-third distance from ASIS to the patella
At two-third distance from ASIS to the patella, the RFCSA
measurement in the patient cohort was 246±79 vs 251
±85 mm2 for linear and curvilinear probes, respectively
(2.0% difference), with CVs of 2.7% and 4.1%. The ICC
for these measurements was 0.98. For the healthy sub-
jects the measurements taken using the linear and curvi-
linear probes were 351±97 and 366±115 mm2 (4.3%
difference), respectively. The CV for the linear probe
measurements was 2.7% and for curvilinear probe 2.4%,
with an ICC of 0.95.
Study 2: Intra-rater and inter-rater agreement of RFCSA
measurement using a curvilinear probe
Participants
Ten healthy subjects were recruited, eight females (32
±6 years) with RFCSA measurements performed on two
separate occasions.
Intra-rater agreement
RFCSA at two-third distance from ASIS to patella at visit 1
was 558±141 mm2 and at visit 2, 549±129 mm2 (1.6% dif-
ference), with a CV of 2.5%. At three-fifth distance from
ASIS and patella, the RFCSA for visit 1 was 699±164 mm
2
and for visit 2, 703±164 mm2 (0.5% difference), with
a CV of 2.6%. Overall, the ICC for all measurements,
at two-third and three-fifth distances, was 0.98
(operator SM).
Inter-rater agreement
Ten patients with chronic respiratory failure were
recruited, including five males (70.2±10.3 years) with a
BMI of 33.6±8.9 kg/m2. At two-third distance, the RFCSA
was 531±249 mm2 (operator SM) and 513±215 mm2
(operator AT), demonstrating a 3.4% difference
between the two measurements, with respective CVs for
the measurements of 4.1% and 4.0%, and an ICC of
0.88. At three-fifth distance, there was no difference in
RFCSA measurements between the two operators, for
operator SM, the mean RFCSA was 672±249 mm
2 and for
operator AT, 672±302 mm2, with CVs of 3.6% and 7.9%,
respectively. The ICC was 0.98. Bland-Altman analysis
demonstrated satisfactory agreement between the opera-
tors (figure 3C). The overall ICC, using RFCSA data from
the two-third and three-fifth distances, was 0.95.
Study 3: RFCSA agreement measured from whole and
spliced images using the linear probe
Participants
Comparison of the whole and spliced image RFCSA
measurement using the linear probe from the healthy
subject and patient cohorts in study 1 was performed
(n=32).
Figure 2 Rectus femoris
cross-sectional area (RFCSA)
image acquired using (A) linear
ultrasound probe at two-third
distance (same subject) and (B)
curvilinear ultrasound probe at
two-third distance (same subject).
Table 1 RFCSA measurements taken by linear and curvilinear probes
Group Linear Curvilinear ICC p Value
2/3 distance
n=32
308±104 mm2 320±117 mm2 0.97 0.8
3/5 distance
n=14
327±103 mm2 334±117 mm2 0.98 0.93
ICC, intraclass correlation coefficient; RFCSA, rectus femoris cross-sectional area.
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RFCSA measured at two-third distance from ASIS and
superior border of the patella
There was no difference between the whole and spliced
RFCSA measurements taken using the linear probe (308
±104 vs 263±147 mm2, 14.6% difference; p=0.34), with
an ICC of 0.98. CV was 3.1% for spliced linear images.
Bland-Altman analysis of whole and spliced linear RFCSA
measurements demonstrated the majority of values were
within the 95% confidence limits of −188.4 to 262.4,
with a bias of 37.0±115.0 mm2 (figure 3D).
RFCSA measured at three-fifth distance from ASIS and
superior border of the patella
There was no difference between the whole and spliced
linear RFCSA images (321±144 vs 327±103 mm
2, 1.9% dif-
ference; p=0.82), with an ICC of 0.99. CV was 5.4% for
the spliced images. Bland-Altman analysis demonstrated
a bias of 15.1±88.5 mm2, again with the majority of
values lying within the 95% confidence limits (−158.5 to
188.6 mm2, figure 3E)
With retrospective analysis, a difference was demon-
strated in the time taken to perform the scans using the
spliced method compared to using whole image acquisi-
tion (3.3±1.5 min vs 1.5±0.9 min, p=0.002).
Study 4: To investigate the relationship between RFCSA
and physical activity during the acute phase and recovery
phase of an exacerbation of COPD
Patients
Seventeen patients were recruited. Baseline character-
istics are reported in table 2. RFCSA was measured within
48 h of admission to hospital and at 4 weeks post-
discharge. RFCSA measurement at admission was 536
±310 mm2 at three-fifth the distance and 427±249 mm2
at two-third the distance from ASIS to patella, measured
using a curvilinear probe. At neither the three-fifth
Figure 3 (A) Bland-Altman plot of linear probe and curvilinear probe rectus femoris cross-sectional area (RFCSA) measurements
at two-third distance from anterior superior iliac spine and patella. (B) Bland-Altman plot of linear probe and curvilinear probe
RFCSA measurements at three-fifth distance from anterior superior iliac spine and patella. (C) Bland-Altman plot of two
independent operator measurements of RFCSA using a curvilinear probe at three-fifth distance from anterior superior iliac spine
and patella. (D) Bland-Altman plot of whole and spliced RFCSA measurements using linear probe at two-third distance from
anterior superior iliac spine and patella. (E) Bland-Altman plot of whole and spliced RFCSA measurements using linear probe at
three-fifth distance from anterior superior iliac spine and patella.
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distance (−9±230 mm2, 4.8%; p=0.67) nor at the
two-third distance (−22.4±158 mm2, 0.6%; p=0.52) was
there change in RFCSA between admission and follow-up
at 4 weeks.
Relationship between physical activity and RFCSA during
AECOPD
Sixteen of the participants underwent triaxial accelerom-
eter activity monitoring during hospital admission and
during the 4-week follow-up period after discharge.
There was a direct correlation observed between admis-
sion RFCSA (532±319 mm
2) and BMI (24.8±7.7 kg/m2;
r=+0.65, p=0.018, figure 4A), and between RFCSA at
admission (532±319 mm2) and activity levels at 4 weeks
post-hospital discharge (activity count 150 610±91 006
AU; r=+0.75, p=0.006). Interestingly, there were no corre-
lations observed between RFCSA at admission and age,
length of stay or exacerbation frequency. At 4 weeks post-
hospital discharge, 12 patients had continued to wear
the accelerometer, with a direct relationship observed
between: RFCSA (409±192 mm
2) and activity count
(180 735 ±78 702 AU; r=+0.76, p=0.006, figure 4B); and
RFCSA and BMI (r=0.58, p=0.04). There were no correla-
tions observed between forced expiratory volume at 1 s
and age, or activity levels.
DISCUSSION
The current study has demonstrated that, despite the
technical limitations of using the lower frequency
curvilinear ultrasound probe, particularly in terms of
image resolution, the measurement of RFCSA using the
curvilinear probe has satisfactory agreement with the
measurement obtained using the standard higher fre-
quency linear probe. The curvilinear probe demon-
strated superiority over the linear probe, as it was able to
acquire, on every occasion, the whole RFCSA image
whereas this was not possible using the linear probe,
especially in patients with substantial muscle bulk and
excess subcutaneous fat. Furthermore, fewer whole
RFCSA images were acquired by the linear probe at three-
fifth distance from the ASIS to the superior border of
the patella compared to two-third distance, and the clin-
ician should consider using the lower frequency curvilin-
ear probe when using the three-fifth landmark distance.
In addition, the curvilinear probe was shown to have sat-
isfactory inter-rater and intra-rater agreement, which has
confirmed the clinical usefulness of the curvilinear
probe. Moreover, the inter-rater and intra-rater RFCSA
agreement of the curvilinear probe was greater at three-
fifth distance, and this further supports the use of the
lower frequency curvilinear probe at three-fifth distance
from the ASIS to the superior border of the patella.
There was no difference between the spliced and whole
image measurement of RFCSA when using the linear
probe, albeit it must be acknowledged that the differ-
ence between the whole and spliced images was less at
three-fifth distance from ASIS to the superior border of
the patella, and thus, if the clinician uses the spliced
image, the three-fifth distance would be preferred.
Finally, the curvilinear probe has clinical acceptability to
monitor the trajectory of change of RFCSA in patients
with COPD during the acute and recovery stage of an
exacerbation.
TECHNICAL IMPLICATIONS OF THE STUDY
Image acquisition using the curvilinear probe showed
satisfactory inter-rater, intra-rater and interoccasion reli-
ability. This is consistent with a previous non-clinical
study that investigated the differences between the curvi-
linear and linear ultrasound probe using fluid-filled
vessels as the test objects. In the study by Warner et al,





Admission FEV1 (L) 0.7±0.2
Admission FVC (L) 1.5±0.5
Length of stay (days) 6.2±7.0
All values are mean±SD.
BMI, body mass index; COPD, chronic obstructive pulmonary
disease; F, female; FEV1, forced expiratory volume in 1 s; FVC,
forced vital capacity; M, male.
Figure 4 (A) Correlation between rectus femoris cross-sectional area (RFCSA) at admission and body mass index. (B)
Correlation between RFCSA at admission and activity at 4-week follow-up.
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the intra-rater and inter-rater reliabilities were high,
however, the differences in measurements between the
two probes varied with the simulation and the model of
ultrasound machine employed, albeit the difference was
small at <50 mm2. Furthermore, in agreement with
Hammond et al,8 we have shown high intertransducer,
inter-rater, intra-rater and intraoccasion agreement. It
must be highlighted, however, that the study by
Hammond et al8 was performed on a small group of par-
ticipants and, surprisingly, the measurements were per-
formed at three-fourth the distance between the ASIS
and superior border of the patella, a distance that has
not been validated against quadriceps muscle strength,
quadriceps muscle endurance, exercise capacity or other
clinical variables, unlike the three-fifth and two-third dis-
tances.1–3
The current study has demonstrated that the splicing
method could be the technique to use if an adequately
sized linear probe or curvilinear probe is not available,
and that this technique can be used in healthy, chronic
and acute patient populations. In addition, the measure-
ments of RFCSA by linear and curvilinear ultrasound
probes are not significantly different, as demonstrated
by the small differences between measurements, high
ICC and low CV. The ICC using the curvilinear probe
and splicing images using a linear probe was 97%, indi-
cating that both techniques could be used to measure
RFCSA in patients in whom a linear probe is unable to
visualise the whole area of the muscle. This is wholly
relevant to the RFCSA measurement at three-fifth dis-
tance from ASIS to the superior border of the patella, as
fewer whole RFCSA images were acquired by the linear
probe at this landmark.
CLINICAL IMPLICATIONS
Similarity between measurements of the RFCSA using
different techniques
These findings have demonstrated that RFCSA measure-
ments obtained using three different methods (linear
whole images, spliced linear images and images from a
curvilinear probe) are equally effective in measuring
RFCSA, with the understanding that using a linear or
curvilinear probe is preferential to the splicing method,
due to the greater variability in measurements with this
method. Indeed, the present data support the use of the
lower frequency curvilinear probe at three-fifth distance
from ASIS to superior border of the patella. This is clin-
ically important since respiratory and critical care depart-
ments will have an ultrasound available for venous line
insertion and pleural ultrasound with at least one of the
probes available. Furthermore, in clinical cases where
sequential or follow-up scans are required, these should,
based on the current data, be performed with the same
probe. This has particular clinical utility in the measure-
ment of RFCSA in patients with high muscle mass, such as
young critically ill trauma patients, and patients with an
increased subcutaneous layer such as caused by fluid
overload and obesity, where depth penetration as well as
an extended window width are required.
Application in the acute setting
Ultrasound has previously been used to monitor changes
in RFCSA in the critically ill,
3 to measure response to
resistance training in COPD and healthy subjects,22 and
to correlate RFCSA with muscle strength.
1 These studies
have all used a linear probe. To the best of our knowl-
edge, this is the first study to use a curvilinear probe to
track changes in RFCSA. Although the study numbers
were small in the acute exacerbation cohort, these pre-
liminary data are novel and hypothesis generating. In
addition to demonstrating that the curvilinear ultra-
sound probe can be used to track changes in acutely
unwell patients with COPD, we have shown correlations
between RFCSA at admission and body composition as
well as the level of physical activity at 4 weeks. Indeed, in
a subgroup of these patients, we observed a direct posi-
tive relationship between RFCSA and physical activity at
4 weeks following hospital discharge. This approach
could have clinical importance in patient selection, to
identify those acute patients most likely to benefit from
rehabilitation, which may, in part, explain the lack of
improvement with rehabilitation in a recently published
trial on these patients.23 24 Additionally, Greening et al25
showed that RFCSA was associated with readmission and
mortality following admission with an exacerbation of
COPD, which highlights the requirement to have robust
measures to track the change in RFCSA during an exacer-
bation. The data we have presented from four studies
performed in this paper were detailed physiological
studies, and it is interesting that there were no correla-
tions between RFCSA and frequency of exacerbations; this
may have been due to small sample size—larger studies
will be required to confirm or disprove these findings.
Limitations of the study
In contrast to CT and MRI, which are relatively operator
independent, ultrasound is an operator-dependent mode
of imaging and errors in measurements can occur.
However, we have shown in the current study that the
ultrasound images obtained, using both, the linear and
curvilinear probes were similar, with high intra-rater and
inter-rater agreement with both probes. This was
achieved, in part, by the scans being performed by two
experienced operators and, in particular, attention was
focused on ensuring an optimal standardised operating
protocol for measurement acquisition including avoid-
ance of muscle compression, and accurate probe position
perpendicular to the long axis of the femur. A major limi-
tation of the spliced image method acquired using the
linear ultrasound probe was that it required increased
time for image acquisition compared to the whole image
acquisition technique. This extended time requirement
is also likely to apply to image analysis time, however, this
calculation was not possible retrospectively. There was no
difference in the time taken to obtain images using a
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curvilinear probe compared to a linear probe, but there
was, as expected, a difference between using the curvilin-
ear probe and linear splicing method. Although the dif-
ference in RFCSA measurements using the spliced
method at two-third distance was not significant, the dif-
ference was larger than those obtained using the other
methods. While the authors acknowledge that there was
a difference in the spliced measurements at two-third dis-
tance from ASIS to the superior border of the patella,
this difference was not present at the three-fifth distance,
and as there is no currently established minimal clinically
important difference (MCID) for change in RFCSA,
further research is required to determine the MCID in
various patient groups. Finally, we acknowledge that
there was a difference in the width of the probes, which
resulted in fewer whole images being captured by the
linear probe, albeit that this probe has been commonly
used in previous studies.1 3 12 26 The authors acknow-
ledge that the shape of the probe will influence the
ability to image the underlying muscle in detail, however,
the linear probe is currently the most common probe
used in practice. These current data support the use of
the splicing technique employing the linear probe, if a
curvilinear probe is not available, and that the measure-
ment should be taken at three-fifth distance. The authors
acknowledge that the sample sizes were small and future
work is required to confirm these data in large popula-
tions, particularly, looking at the correlations in the
COPD population, sample size calculations will need to
be calculated in order to detect differences.
CONCLUSION
In healthy subjects and patients with chronic respiratory
disease, the data from these detailed physiological
studies have demonstrated that the use of the lower fre-
quency curvilinear probe is not inferior to that of the
higher frequency linear probe in measuring RFCSA.
Furthermore, there was strong intra-rater and inter-rater
agreement in the use of the curvilinear probe to
measure RFCSA. The RFCSA spliced image method has
limitations and it should only be used when a curvilinear
probe is not available, and the clinician should use the
same method to measure RFCSA when acquiring sequen-
tial follow-up data. The use of the curvilinear ultrasound
probe has been validated in both, stable and acute
patients with chronic respiratory disease, which will
permit extension of the use of the curvilinear probe to
patients where the image depth pentration and width
capture requirements are greater, such as young trauma
patients with high muscle bulk, morbidly obese patients
with significant subcutaneous fat and patients with fluid
overload.
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